Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery.

Serum samples from 9006 women, who delivered in Switzerland in 1990 and 1991, were collected around the country. Of these women, 62.7% were Swiss and 37.3% originated from foreign countries. Samples were first screened for anti-HBc and those found positive were further tested for HBsAg, anti-HBs and anti-HDV. Anti-HBc was found in 640 of the 9006 women (overall prevalence, 7.1%; Swiss, 3.3%; foreigners, 13.5%). Of these 640 positive samples, 61 (9.5%) were positive for HBsAg (without anti-HBs), 467 (73.0%) positive for anti-HBs (without HBsAg) and 8 (1.3%) positive for both HBsAg and anti-HBs. The remaining 104 were thus anti-HBc positive without HBsAg or anti-HBs. These 104 specimens with the so-called "isolated anti-HBc" reactivity represented 1.2% of the whole population or 16.3% of the 640 anti-HBc positive mothers. All were HBV DNA negative (PCR). Anti-HDV antibody was found in only five women. HBsAg was seen in 38 of the cord-blood samples from the anti-HBc positive mothers. In this large sampling, we observed a relatively high seroprevalence of HBV infection. Cases with isolated anti-HBc reactivity, being HBV DNA negative by PCR, were probably non-infectious at the time of blood collection.

[1]  A. Walker,et al.  Toxoplasma infection among pregnant women in Switzerland: a cross-sectional evaluation of regional and age-specific lifetime average annual incidence. , 1995, American journal of epidemiology.

[2]  J. Parry,et al.  Risk behaviour, anti‐HIV and anti‐hepatitis B core prevalence in clinic and non‐clinic samples of gay men in England; 1991–1992 , 1993, AIDS.

[3]  Chien-Jen Chen,et al.  Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: An island‐wide survey , 1993, Journal of medical virology.

[4]  A. Gottschau,et al.  Risk factors for hepatitis B virus infection in heterosexuals attending a venereal disease clinic in Copenhagen. , 1993, Scandinavian journal of infectious diseases.

[5]  J. Giesecke,et al.  Prevalence of hepatitis B virus markers among intravenous drug abusers in Stockholm: impact of heterosexual transmission. , 1993, Scandinavian journal of infectious diseases.

[6]  L. Mascola,et al.  Screening for HIV and hepatitis B virus in Los Angeles County prenatal clinics: a demonstration project. , 1993, Journal of acquired immune deficiency syndromes.

[7]  J. Prieto,et al.  Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. , 1993, Journal of hepatology.

[8]  R. Perrillo Hepatitis B: transmission and natural history. , 1993, Gut.

[9]  M. Kane Progress on the control of hepatitis B infection through immunisation. , 1993, Gut.

[10]  P. Tellini,et al.  Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age , 1992 .

[11]  J. Struve Hepatitis B virus infection among Swedish adults: aspects on seroepidemiology, transmission, and vaccine response. , 1992, Scandinavian journal of infectious diseases. Supplementum.

[12]  J. Saleun Anticorps Anti-HBc chez les donneurs de sang. Répartition par sexes et classes d'âge , 1991 .

[13]  Shibo Jiang,et al.  Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen , 1991, Journal of medical virology.

[14]  N. Linder,et al.  Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk , 1991, Journal of medical virology.

[15]  A. Goudeau,et al.  [Perinatal transmission of the hepatitis B virus in Paris region]. , 1991, Pathologie-biologie.

[16]  M. Rapicetta,et al.  Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy. A survey before mass hepatitis B vaccination. , 1991, The Journal of infection.

[17]  D. S. Bowden,et al.  Digoxigenin-labeled probes for the detection of hepatitis B virus DNA in serum , 1991, Journal of clinical microbiology.

[18]  Ding‐Shinn Chen,et al.  Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. , 1991, The Journal of infectious diseases.

[19]  P. Grob,et al.  [Infection with hepatitis viruses HAV, HBV and HCV as well as with AIDS virus HIV in drug addicts of the Zurich street scene--a prevalence study]. , 1990, Schweizerische medizinische Wochenschrift.

[20]  H. Margolis,et al.  The Changing Epidemiology of Hepatitis B in the United States: Need for Alternative Vaccination Strategies , 1990 .

[21]  R. Miller,et al.  Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique , 1989, Journal of clinical microbiology.

[22]  F. Roudot-thoraval,et al.  [Prevalence of HBs antigen carriers and markers of B virus replication in a population of pregnant women, in France]. , 1989, Gastroenterologie clinique et biologique.

[23]  H. Joller,et al.  [Prevalence of cytomegalovirus, hepatitis B and HIV-1 antibodies in healthy blood donors, hospital patients, kidney transplant recipients, i.v. drug addicts and homosexuals]. , 1989, Schweizerische medizinische Wochenschrift.

[24]  Ching-lung Lai,et al.  Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implications in hepatitis B vaccination programs , 1988, Hepatology.

[25]  K. Hyams,et al.  Maternal‐infant transmission of hepatitis B in Egypt , 1988, Journal of medical virology.

[26]  P. Frei,et al.  [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis]. , 1987, Schweizerische medizinische Wochenschrift.

[27]  J. Wands,et al.  Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. , 1985, The New England journal of medicine.

[28]  R. Huch,et al.  [Incidence of HBsAG in symptom-free pregnant women. Results of screening at the University of Zurich Gynecology Clinic]. , 1984, Schweizerische medizinische Wochenschrift.

[29]  L. Hwang,et al.  Postnatal infectivity of hepatitis B surface antigen-carrier mothers. , 1983, The Journal of infectious diseases.

[30]  Dike Ae Post-transfusion hepatitis B transmitted by HBsAg negative blood containing anti-HBc. , 1981 .

[31]  G. Vyas,et al.  Biology of hepatitis B virus. , 1981, Science.

[32]  J. Rakela,et al.  Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. , 1981, Gastroenterology.

[33]  J. Hoofnagle,et al.  Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. , 1978, The New England journal of medicine.